Skip to content
healthcare.dev

Bupropion hydrochloride (XL)

NDC 0527-2415, Bupropion hydrochloride, tablet, extended release, from Lannett Company Inc..

Product NDC
0527-2415
Status
Listed
Labeler
Lannett Company Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208652
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0527-2415 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • BUPROPION HYDROCHLORIDE150 mg/1

Pharmacologic classes

Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]

Package NDCNDC-11Package
0527-2415-320052724153230 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-32)
0527-2415-4100527241541500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-41)
0527-2415-43005272415431000 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-43)
0527-2415-460052724154690 TABLET, EXTENDED RELEASE in 1 BOTTLE (0527-2415-46)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/15c4e95a-d203-4caf-b6c7-44792355cb76

Use it

Look up 0527-2415 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0527-2415 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0527-2415. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.